Chest radiation is used to treat children with Hodgkin and non-Hodgkin lymphoma as well as lung metastases in various solid tumors. But radiation itself is a potential cancer risk, including an ...
Understanding the principles of cancer evolution is important in designing a therapeutic strategy. A research group at The Institute of Medical Science, The University of Tokyo (IMSUT) announced a new ...
Family caregivers are a critical extension of the healthcare team, yet little attention is paid to providing support, information, and training to caregivers in clinical practice. This randomized ...
Limited access to adequate cancer surgery training is one of the driving forces behind global inequities in surgical cancer care. Affordable virtual reality (VR) surgical training could enhance ...
Metastasis is the most lethal cause of cancer-associated deaths 1. The metastasis cascade includes cancerous cells detachment from the primary tumor, intravasation into the circulatory or lymphatic ...
Imatinib, better known as Gleevec, was hailed as a "miracle" cancer drug when it entered the market in the early 2000s. Though it has been highly successful at treating early-stage chronic myeloid ...
A new paper published in EPJ Plus and authored by Eduardo De Paiva, from the Division of Medical Physics at the Institute of Radiation Protection and Dosimetry, Rio de Janeiro, Brazil, pits the gold ...
Photodynamic therapy outcome modelling for patients with spinal metastases: a simulation-based study
Spinal metastases often occur in the advanced stages of breast, lung or prostate cancer, resulting in a significant impact on the patient’s quality of life. Current treatment modalities for spinal ...
Development of a performance status prediction model for use in administrative data analyses. Background: Technical studies suggest CT-based simulation can improve the therapeutic ratio for thoracic ...
LONDON & BUDAPEST, Hungary--(BUSINESS WIRE)--Turbine, a company developing a cell behavior simulation platform, today announced the closing of a €20 million Series A financing round. Mercia and MSD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results